[Therapy of the disseminated intravascular coagulation syndrome in obstetrical practice].
D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006438:Hemodilution / Q000379:methods; D006439:Hemodynamics / Q000187:drug effects; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy; D007744:Obstetric Labor Complications / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D010276:Parasympatholytics; D010952:Plasma Substitutes; D006493:Heparin
Terapiia sindroma disseminirovannogo vnutrisosudistogo svertyvaniia krovi v akusherskoĭ praktike.